Therapeutic dosing of low-molecular-weight heparin may decrease mortality in patients with severe COVID-19 infection

BACKGROUND: Venous thromboembolism or extensive thrombosis is relatively common in patients with severe COVID-19 infection and has been associated with increased mortality. During the current COVID-19 pandemic, several prophylactic doses and types of low-molecular-weight heparin (LMWH) are being use...

Descripción completa

Detalles Bibliográficos
Autores principales: Canoglu, Kadir, Saylan, Bengu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733641/
https://www.ncbi.nlm.nih.gov/pubmed/33307734
http://dx.doi.org/10.5144/0256-4947.2020.462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733641/
https://www.ncbi.nlm.nih.gov/pubmed/33307734
http://dx.doi.org/10.5144/0256-4947.2020.462

Ejemplares similares